Peptide questions · Orforglipron
Orforglipron half-life: how long it stays in your system
Reviewed Evidence: EstablishedPublished by PepVault
Orforglipron’s half-life is about 1.2–2 days (29–49 hours), the figure on its drug label.
Half of a dose of orforglipron is gone after about 1.2–2 days, and about 97% after 6–10 days, five half-lives.
How much orforglipron is left after each half-life
Each half-life halves whatever is left. Starting from one dose of orforglipron, about 50% remains after 1.2–2 days, 25% after 2.4–4.1 days and 12.5% after 3.6–6.1 days.
| Half-lives | Time after a dose | Left | Cleared |
|---|---|---|---|
| 1 | about 1.2–2 days | 50% | 50% |
| 2 | about 2.4–4.1 days | 25% | 75% |
| 3 | about 3.6–6.1 days | 12.5% | 87.5% |
| 4 | about 4.8–8.2 days | 6.3% | 93.8% |
| 5 | about 6–10 days | 3.1% | 96.9% |
| 7 | about 8.5–14 days | 0.8% | 99.2% |
What is left of one dose, half-life by half-life: an estimate from the stated figure.
By about 6–10 days (five half-lives) 96.9% of a single dose of orforglipron has cleared, and by about 8.5–14 days (seven) 99.2%. A day after a dose about 56.3–71.2% of it is still there.
This is elimination arithmetic: it describes how the level in the blood falls after a dose, not how long a drug test can find it, and this page makes no claim about detection.
The arithmetic assumes the body clears the compound at a steady rate, the simple one-compartment model the half-life calculator uses; absorption from under the skin, the route and the person all move the real curve.

Model. Individual results vary.
Orforglipron on a regular schedule
The library lists orforglipron’s frequency as “Daily”, a dose every 24 hours, which is 0.5–0.8 of its half-lives.
When the next dose of orforglipron comes, about 56.3–71.2% of the one before is still there, so the doses overlap and the level climbs over the first ones. It stops climbing after 4 to 5 half-lives, about 4.8–10 days, which on this schedule is about 5–11 doses. From then on each peak of orforglipron sits about 2.3–3.5 times as high as a single dose’s.
An estimate on the library’s typical schedule from the half-life above, not a measurement.
Orforglipron against other metabolic & GLP-1 compounds
The library states a half-life with a number for 20 of its metabolic & GLP-1 compounds. Orforglipron’s is the sixth shortest of the 20: the shortest is oxytocin at about 1–6 minutes, the longest eloralintide at about 14 days (336 hours).
| Compound | Half-life | Kind of figure |
|---|---|---|
| Oxytocin | about 1–6 minutes | source not given |
| Pramlintide | about 48 minutes | drug label |
| Exenatide | about 2.4 hours | drug label |
| Setmelanotide | about 11 hours | drug label |
| Liraglutide | about 13 hours | source not given |
| Orforglipron | about 1.2–2 days (29–49 hours) | drug label |
| Amycretin | about 3.7 days (88 hours) | measured in people |
| Dulaglutide | about 5 days (120 hours) | drug label |
| Tirzepatide | about 5 days (120 hours) | drug label |
| Ecnoglutide | about 5.5 days (132 hours) | measured in people |
| Enicepatide | about 5.5 days (132 hours) | measured in people |
| Retatrutide | about 6 days (144 hours) | measured in people |
| Cagrilintide | about 7 days (168 hours) | measured in people |
| CagriSema | about 7 days (168 hours) | measured in people |
| Semaglutide | about 7 days (168 hours) | drug label |
| Semaglutide (oral) | about 7 days (168 hours) | source not given |
| VK2735 | about 9 days (216 hours) | measured in people |
| Mazdutide | about 10 days (240 hours) | drug label |
| Petrelintide | about 10 days (240 hours) | measured in people |
| Eloralintide | about 14 days (336 hours) | measured in people |
What the half-life explains about how often orforglipron is dosed
Spacing doses of orforglipron 0.5–0.8 half-lives apart means more than half of each dose is still there at the next one, which is why orforglipron builds up over its first weeks and then holds a fairly even level.
The library’s timing note
One tablet a day, any time, with or without food, swallowed whole (label). The label climbs from 0.8 mg to 2.5 mg and then 5.5 mg, at least 30 days per step, and may continue to 9, 14.5 or 17.2 mg by response and tolerability. Per the label, a missed dose is taken as soon as possible but never doubled, and after 7 or more missed days in a row the climb restarts at a lower dose.
Where the orforglipron figure comes from
As the library states it
~29–49 hours (FDA label; steady levels after about a week of daily tablets)
Orforglipron’s half-life comes from its drug label, the figure the regulator reviewed, measured in people in the studies behind the approval.
Our study page on how orforglipron moves through the body:
Questions people ask
What is the half-life of orforglipron?
Orforglipron’s half-life is about 1.2–2 days (29–49 hours), the figure on its drug label. Half of a dose of orforglipron is gone after about 1.2–2 days, and about 97% after 6–10 days, five half-lives.
How long does orforglipron stay in your system?
By elimination arithmetic, about 96.9% of a single dose of orforglipron has cleared after five half-lives, about 6–10 days, and 99.2% after seven, about 8.5–14 days. That is how its level in the blood falls, not a drug-test detection window.
How long does orforglipron take to reach steady state?
On the library’s schedule (Daily), orforglipron’s level stops climbing after 4 to 5 half-lives, about 4.8–10 days, or 5–11 doses.
Is the half-life of orforglipron measured in people?
Orforglipron’s half-life comes from its drug label, the figure the regulator reviewed, measured in people in the studies behind the approval.